Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Alize J Ferrari, Masayuki Teramoto, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Robert Ancuceanu, Theo Vos et al.|The Lancet Public Health|2025Cited by 186
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Mohammed Z. Allouh, Oyelola A. Adegboye et al.|The Lancet|2025Cited by 153
Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021Jiyeon Oh, Mohammad S. Alyahya, Soeun Kim et al.|The Lancet Respiratory Medicine|2025Cited by 144
Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysisAuthia P Gray, Hasan Y. Alniss, Erin Chung et al.|The Lancet Global Health|2025Cited by 90